Skip to main content
CV logo

CV · CapsoVision, Inc · Metrics

Track CV — free
$6.99 +0.19 (+2.79%) At close · Oct 23
Market Cap
$349.83M
Shares
50.05M
Volume · Oct 23 320.24K Avg daily vol (3M) 160.72K

CV metrics

79 of 122 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$6.99
Market cap
$349.83M

Price action

20 metrics
Price change (1W)
+7.0%
Price change (30D)
+5.1%
Price change (3M)
+7.7%
Price change (6M)
+15.2%
Price change (YTD)
-34.6%
Price change (1Y)
+42.4%
Trailing year
Price change (5Y)
—
52-week high
$14.42
52-week low
$4.59
Change from 52-week high
-51.5%
Change from 52-week low
+52.3%
Annualized volatility
98.3%
Annualized volatility (3M)
52.4%
Beta
0.8
RSI (14D)
61.1
Price vs SMA 50
+10.0%
Price vs SMA 200
+10.4%
Avg volume (3M)
160,722
Relative volume
2.0
Average dollar volume
$1.04M

Company

3 metrics
Sector
Healthcare
Industry
Medical Devices
Shares outstanding
50.05M

Valuation

12 metrics
P / E (TTM)
2.2
Trailing earnings · reciprocal yield 45.5%
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
25.2×
reciprocal yield 4.0%
P / book
26.6
reciprocal yield 3.8%
FCF yield
-8.0%
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
-8.5%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-08-13

Profitability

9 metrics
Gross margin
50.9%
Operating margin
-217.1%
Trailing 12 months
Net margin
-214.7%
Gross profit (TTM)
$7.07M
Operating profit (TTM)
−$30.16M
Net income (TTM)
−$29.83M
Trailing 12 months
Diluted EPS (TTM)
$3.18
FCF margin
-200.8%
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
$0.29
Gross profit per diluted share (TTM)
$0.15
Operating profit per diluted share (TTM)
$-0.63
EBITDA per diluted share (TTM)
$-0.63
Net income per diluted share (TTM)
$-0.63
Operating cash flow per diluted share (TTM)
$-0.58
Free cash flow per diluted share (TTM)
$-0.58
Capital expenditures per diluted share (TTM)
$0.00
R&D per diluted share (TTM)
$0.45
Stock compensation per diluted share (TTM)
$0.03
Book value per share
$0.28

Growth

11 metrics
Revenue growth YoY
+9.9%
Year over year
Net income growth YoY
—
Revenue (TTM)
$13.89M
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+2,078.6%
Year over year · more shares
Revenue CAGR (3Y)
—
Revenue CAGR (5Y)
—
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
-226.6%
Return on assets
-160.6%
Debt / equity
—
Current ratio
3.4
EBITDA (TTM)
−$29.93M
Free cash flow (TTM)
−$27.89M
Quick ratio
2.4
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
—
Total assets
$18.57M
Total debt
—

Cash flow & spend

7 metrics
Operating cash flow (TTM)
−$27.82M
Capital expenditures (TTM)
$68,000
R&D (TTM)
$21.55M
SG&A (TTM)
—
Stock compensation (TTM)
$1.42M
R&D / revenue
155.2%
Stock compensation / revenue
10.2%

Ownership (13F)

9 metrics
13F filers
49
13F filer change QoQ
-2
Institutional ownership
10.2%
Conviction holders (share of 13F filers)
0.0%
Crowding (high-turnover and private-fund holders)
0.2%
Private-fund adviser ownership
0.2%
Active holders' share change QoQ
+10.0%
Holder tenure
3.3
Price vs estimated holder cost
+23.8%

Ownership (registered funds)

1 metrics
Index-fund ownership
6.4%

Short interest

3 metrics
Short interest
4.2%
Latest settlement · 5.4 days to cover
Days to cover
5.4d
Short-squeeze score
75 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
Flagged
Key facts CIK 1378325 CUSIP 140935107 13F (30d) 7 filings 7 filers Visit website Investor relations